Skip to main content
Log in

Is symptomatic treatment an option for a boy with clinically significant psychotic-like experiences and depressed mood? Comment on Ruhrmann et al., “intervention in at-risk states for developing psychosis.” (Eur Arch Psychiatry Clin Neurosci 260 Suppl 2:S90–94)

  • Letter to the Editor
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Findling RL, Robb A, Nyilas M, Forbes RA, Jin N, Ivanova S, Marcus R, McQuade RD, Iwamoto T, Carson WH (2008) A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. Am J Psychiatry 165:1432–1441

    Article  PubMed  Google Scholar 

  2. Fusar-Poli P, Valmaggia L, McGuire P (2007) Can antidepressants prevent psychosis? Lancet 370:1746–1748

    Article  PubMed  Google Scholar 

  3. Kobayashi H, Morita K, Takeshi K, Koshikawa H, Yamazawa R, Kashima H, Mizuno M (2009) Effects of aripiprazole on insight and subjective experience in individuals with an at-risk mental state. J Clin Psychopharmacol 29:421–425

    Article  PubMed  CAS  Google Scholar 

  4. McGorry PD, Yung A, Phillips L (2001) Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophr Res 51:17–29

    Article  PubMed  CAS  Google Scholar 

  5. Meyer SE, Bearden CE, Lux SR, Gordon JL, Johnson JK, O’Brien MP, Niendam TA, Loewy RL, Ventura J, Cannon TD (2005) The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV. J Child Adolesc Psychopharmacol 15:434–451

    Article  PubMed  Google Scholar 

  6. Moreno C, Arango C, Parellada M, Shaffer D, Bird H (2007) Antidepressants in child and adolescent depression: where are the bugs? Acta Psychiatr Scand 115:184–195

    Article  PubMed  CAS  Google Scholar 

  7. Ruhrmann S, Schultze-Lutter F, Bechdolf A, Klosterkotter J (2010) Intervention in at-risk states for developing psychosis. Eur Arch Psychiatry Clin Neurosci 260(Suppl 2):S90–94

    Article  PubMed  Google Scholar 

  8. Ruhrmann S, Schultze-Lutter F, Klosterkotter J (2010) Probably at-risk, but certainly ill–advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res 120:23–37

    Article  PubMed  Google Scholar 

  9. Woods SW, Tully EM, Walsh BC, Hawkins KA, Callahan JL, Cohen SJ, Mathalon DH, Miller TJ, McGlashan TH (2007) Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study. Br J Psychiatry Suppl 51:s96–s101

    Article  Google Scholar 

  10. Yung AR, McGorry PD (1996) The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 22:353–370

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chen-Chung Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, HY., Chiu, YN. & Liu, CC. Is symptomatic treatment an option for a boy with clinically significant psychotic-like experiences and depressed mood? Comment on Ruhrmann et al., “intervention in at-risk states for developing psychosis.” (Eur Arch Psychiatry Clin Neurosci 260 Suppl 2:S90–94). Eur Arch Psychiatry Clin Neurosci 262, 179–180 (2012). https://doi.org/10.1007/s00406-011-0210-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-011-0210-x

Keywords

Navigation